AJP - Heart and Circulatory Physiology, Vol 270, Issue 4 1355-H1362, Copyright © 1996 by American Physiological Society

ARTICLES

Inhibition of cytochrome P-450 attenuates hypoxemia of acute lung injury in dogs

A. H. Stephenson, R. S. Sprague, N. L. Weintraub, L. McMurdo and A. J. Lonigro
Department of Pharmacological and Physiological Science, Saint Louis University, School of Medicine, Missouri 63104, USA.

The intravenous administration of ethchlorvynol (ECV), in dogs, resulted in an acute lung injury (ALI) characterized by a 200 +/- 80% increase in venous admixture and a 142 +/- 30% increase in extravascular lung water (EVLW). Pretreatment with the cytochrome P-450 inhibitor 8-methoxypsoralen prevented the ECV-induced increase in venous admixture but not the increased EVLW. These findings parallel those reported for cyclooxygenase inhibition in ECV-induced ALI and suggest that an arachidonic acid (AA) metabolite of pulmonary cytochrome P-450 activity may mediate the increase in venous admixture of ALI. We demonstrate that canine pulmonary microsomes metabolize [1-(14)C]AA to a variety of products, including the cytochrome P-450 metabolites 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid (EET). In prostaglandin F2 alpha-contracted, isolated pulmonary venous rings, 5,6-EET induced relaxation in a concentration-dependent manner. This action of 5,6-EET was prevented by indomethacin (10(-5) M). These results suggest that may serve as the cyclooxygenase-dependent endogenous pulmonary vasodilator responsible for the increase in venous admixture of ECV-induced ALI.

This article has been cited by other articles:

				D. F. Alvarez, E.-A. B. Gjerde, and M. I. Townsley Role of EETs in regulation of endothelial permeability in rat lung Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L445 - L451. [Abstract] [Full Text] [PDF]

				A. H. Stephenson, R. S. Sprague, J. L. Losapio, and A. J. Lonigro Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2153 - H2161. [Abstract] [Full Text] [PDF]

				M. Fuloria, T. K. Smith, and J. L. Aschner Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L383 - L389. [Abstract] [Full Text] [PDF]

				R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]

				E. R. Jacobs and D. C. Zeldin The lung HETEs (and EETs) up Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10. [Abstract] [Full Text] [PDF]

				L. KISS, H. SCHÜTTE, K. MAYER, H. GRIMM, W. PADBERG, W. SEEGER, and F. GRIMMINGER Synthesis of Arachidonic Acid-Derived Lipoxygenase and Cytochrome P450 Products in the Intact Human Lung Vasculature Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1917 - 1923. [Abstract] [Full Text]

				C. L. Ivey, A. H. Stephenson, and M. I. Townsley Involvement of cytochrome P-450 enzyme activity in the control of microvascular permeability in canine lung Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L756 - L763. [Abstract] [Full Text] [PDF]

				A. H. Stephenson, R. S. Sprague, and A. J. Lonigro 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H100 - H109. [Abstract] [Full Text] [PDF]